semaglutide throwing up bile GLP-1 Side Effects and Semaglutide: Why Smart Biomarker Monitoring Matters Semaglutide Side Effects: Common vs

This hormone often leads the body to store more fat in the belly area

Key Takeaways Feeling cold on semaglutide is usually harmless and may subside, but persistent chills, weakness, dizziness, or changes in circulation should be discussed with your medical provider

Medications and other Remedies for Constipation: Colace-OTC stool softener Dulcolax laxative OTC Senna OTC Magnesium can sometimes be helpful Lactulose (prescription) Linaclotide (prescription) Lubiprostone (prescription) Dietary modifications for constipation: Eating smaller, more frequent meals and avoiding high-fat foods can help minimize gastrointestinal discomfort

But a validated clinical diagnostic test does not yet exist

Safety is the cornerstone of every operation performed by Dr

This should include: Comprehensive medication review : Documenting all prescribed medications, over-the-counter products, and supplements to identify potential interactions, particularly noting fluoxetine's strong CYP2D6 inhibition Mental health evaluation : Assessing depression severity, suicide risk, and treatment response to fluoxetine Weight and metabolic parameters : Recording baseline weight, BMI, waist circumference, blood pressure, and relevant blood tests (HbA1c, lipid profile, liver function) Renal function and electrolytes : Particularly sodium levels, given the risk of SSRI-induced hyponatraemia Cardiovascular assessment : Particularly important given semaglutide's potential effects on heart rate Gastrointestinal and gallbladder history : Identifying pre-existing conditions that might be exacerbated Ophthalmological assessment : For patients with diabetes, as rapid improvement in glycaemic control may worsen diabetic retinopathy Ongoing monitoring should occur at regular intervals, typically: Monthly initially : During Wegovy dose escalation (following the standard titration schedule from 0.25 mg to 2.4 mg over 1620 weeks) Every 36 months : Once stable doses are achieved, monitoring weight, mental health status, side effects, and treatment adherence As clinically indicated : More frequent review if concerns arise Dose adjustments may be necessary based on individual response